For decades, Alzheimer's disease genetics research has centered on European ancestry populations, leaving African Americans — who face disproportionately higher dementia risk — with incomplete risk models. A newly published neuroimaging study challenges the assumption that APOE-ε4 is the dominant functional driver of early Alzheimer's pathology across all ancestries, suggesting that a different genetic variant may exert stronger effects on brain network health in older African Americans.
The study examined 146 older African Americans (mean age ~70) carrying either the ABCA7 rs115550680 risk allele or the APOE-ε4 allele, using resting-state fMRI to quantify medial temporal lobe (MTL) dynamic network flexibility — a measure of the brain's capacity to reconfigure its connectivity patterns over time. Carriers of the ABCA7 rs115550680 allele demonstrated significantly lower MTL flexibility compared to both non-carriers (p = .042) and APOE-ε4 carriers (p = .030), suggesting greater disruption to adaptive network function. These individuals also exhibited hypertrophy in the left anterior hippocampus and bilateral entorhinal cortex — regions among the first affected by Alzheimer's pathology — a finding that may reflect compensatory neuroplasticity or early pathological remodeling preceding volume loss.
This research matters for several interconnected reasons. ABCA7 encodes an ATP-binding cassette transporter involved in lipid metabolism and amyloid clearance; rs115550680 is a loss-of-function frameshift variant roughly four times more common in African ancestry populations than European ones, yet it remains dramatically understudied relative to APOE-ε4. The finding that this variant produces measurably greater functional disruption than APOE-ε4 in this cohort challenges a European-centric hierarchy of genetic risk. However, the sample of 146 participants limits statistical power, and the cross-sectional design prevents causal inference — we cannot determine whether reduced flexibility precedes cognitive decline or co-occurs with it. Replication in larger longitudinal cohorts is essential. Still, the directional signal here is meaningful: ancestry-specific genetic screening and neuroimaging protocols may be warranted for more equitable early detection.